Bear...Can we conclude that based on this data, ABL would compete with current medicine for Congestive Heart Failure?
Or is this data only related to MACE prevention only?
ABL Placebo
First hospitalization for congestive heart failure 29 (2.4%) 48 (4.0%
First and recurrent hospitalization for congestive heart failure 35 70
Koo